# Nuclide record nct06754085 (trial). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/trials/nct06754085/>
  a schema:MedicalTrial ;
  nuclide:kind "trial" ;
  schema:identifier "nct06754085", "NCT06754085" ;
  schema:name "Study of 18F-Florastamin PET/CT Imaging in Patients With Suspected Recurrence of Prostate Cancer"@en ;
  schema:description "A phase 3 trial of Florastamin[18F] Injection in prostate cancer, run by HTA Co., Ltd., completed in June 2026 with no results posted yet."@en ;
  schema:url <https://nuclide.cc/trials/nct06754085/> ;
  schema:dateModified "2026-10-04"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06754085> ;
  nuclide:status "completed" ;
  nuclide:tag "pipeline", "ctgov-ingest" ;
  nuclide:phase "3" ;
  nuclide:related <https://nuclide.cc/isotopes/f-18/> ;
  nuclide:indications <https://nuclide.cc/indications/prostate/> ;
  nuclide:technologies <https://nuclide.cc/technologies/pet/>, <https://nuclide.cc/technologies/pet-ct/> ;
  nuclide:drugs <https://nuclide.cc/drugs/florastamin-f18/> .